| Kasey Gilbert, | |
|
4136 W Tilghman St, Allentown, PA 18104-4428 | |
| (484) 822-6040 | |
| Not Available |
| Full Name | Kasey Gilbert |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4136 W Tilghman St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447959952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kasey Gilbert, 315 N Lobb Ave, Pen Argyl, PA 18072-1022 Ph: (267) 772-1407 | Kasey Gilbert, 4136 W Tilghman St, Allentown, PA 18104-4428 Ph: (484) 822-6040 |
News Archive
Scientific breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the Walter E. Washington Convention Center, April 17-21, for the AACR 101st Annual Meeting 2010.
The HonorHealth Research Institute and HonorHealth announced today the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection.
Thirty-three million children worldwide suffer from moderate acute malnutrition. It affects human development and generally, increases susceptibility to illness. Unfortunately, the nutritional supplements and aid that these children may receive today is based upon dated standards developed for adults or otherwise intended for children with severe acute nutrition.
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
› Verified 8 days ago
Adrienne Westheim, M.S, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 930 Springhouse Rd, Allentown, PA 18104 Phone: 610-390-5014 Fax: 610-398-7134 | |
Bailey Mckeon, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1925 W Turner St, Allentown, PA 18104 Phone: 610-794-5264 | |
Sarah Wanuga, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Megan Pellek, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 S Cedarbrook Rd, Allentown, PA 18104 Phone: 610-395-3727 Fax: 610-395-7919 | |
Cailee Carmella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4136 W Tilghman St Apt 5, Allentown, PA 18104 Phone: 484-822-6040 | |
Ellen Susan Krajcir, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Tiffany Ferreira, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 888-402-5846 |